levofloxacin has been researched along with Opportunistic Infections in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Kanderi, T; Komanduri, S; Mansoora, Q; Shah, K; Shrimanker, I; Yumen, A | 1 |
| Duan, Z; Li, C; Liu, Y; Qin, J; Ying, C | 1 |
| Bagai, S; Gupta, KL; Kohli, HS; Kumar, H; Kumar, V; Muthu, V; Nayak, S; Ramachandran, R; Rathi, M; Sharma, A | 1 |
| Li, J; Li, XN; Zhang, P; Zhang, YZ | 1 |
| Patel, S; Roy, S; Weaver, MD | 1 |
| Gotoh, M; Katagiri, S; Nakamura, I; Ohyashiki, K; Yoshizawa, S | 1 |
| Eroğlu, C; Günaydın, M; Güney, AK; Karadağ, A; Usta, E; Yanık, K | 1 |
| Hayashi, Y; Hino, M; Hirose, A; Kakeya, H; Koh, H; Koh, S; Nakamae, H; Nakamae, M; Nakane, T; Nakashima, Y; Nishimoto, M; Yamada, K | 1 |
| Couderc, L; Lémée, L; Marguet, C; Morisse-Pradier, H | 1 |
| Alvarez Corral, G; Clavero Farré, C; García Pérez, MJ; Giménez Garrido, F; Gracia Escudero, A; Martín González, M; Reyes Bertos, A; Rodríguez Cuartero, A; Villegas Maldonado, G | 1 |
| Marchese, A; Roveta, S; Schito, AM; Schito, GC | 1 |
1 review(s) available for levofloxacin and Opportunistic Infections
| Article | Year |
|---|---|
[Infections in cystic fibrosis: Up-to-date].
Topics: Child; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Early Medical Intervention; Guideline Adherence; Humans; Infant; Levofloxacin; Mycoses; Opportunistic Infections; Respiratory Tract Infections; Treatment Outcome | 2016 |
1 trial(s) available for levofloxacin and Opportunistic Infections
| Article | Year |
|---|---|
[A prospective, controlled, non-randomized study of three cohorts to test the effectiveness of two antibiotics levofloxacin and cotrimoxazol on antibacterial prophylaxis in neutropenic patients].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Humans; Leukemia; Levofloxacin; Lymphoma; Middle Aged; Neutropenia; Ofloxacin; Opportunistic Infections; Prospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
9 other study(ies) available for levofloxacin and Opportunistic Infections
| Article | Year |
|---|---|
Stenotrophomonas maltophilia: An Emerging Pathogen of the Respiratory Tract.
Topics: Aged; Anti-Bacterial Agents; Fatal Outcome; Female; Gram-Negative Bacterial Infections; Heart Arrest; Humans; Levofloxacin; Opportunistic Infections; Pneumonia; Sepsis; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Biofilms; Case-Control Studies; China; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gene Expression; Genes, Bacterial; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Opportunistic Infections; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Levofloxacin based non-rifampicin anti-tuberculous therapy: An effective alternative in renal transplant recipients in resource limited setting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Developing Countries; Drug Costs; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; India; Kidney Transplantation; Levofloxacin; Male; Middle Aged; Opportunistic Infections; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Tuberculosis; Young Adult | 2021 |
Chromobacterium violaceum infection on lower limb skin: A case report.
Topics: Administration, Intravenous; Chromobacterium; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lower Extremity; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Skin; Skin Ulcer; Treatment Outcome | 2021 |
Miliary tuberculosis and herpes pharyngitis after a trip to a developing country: dangers of biologics.
Topics: Adalimumab; Aged, 80 and over; Anti-Bacterial Agents; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Biological Products; Developing Countries; Diagnosis, Differential; Herpes Simplex; Herpesvirus 1, Human; Humans; India; Isoniazid; Levofloxacin; Lung; Male; Opportunistic Infections; Pharyngitis; Pyrazinamide; Tomography, X-Ray Computed; Travel-Related Illness; Tuberculin Test; Tuberculosis, Miliary; Vitamin B 6 | 2018 |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia].
Topics: Amikacin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Humans; Imipenem; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Levofloxacin; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Prednisolone; Treatment Outcome | 2014 |
[Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
Topics: Anti-Infective Agents; Ceftazidime; Chloramphenicol; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Integrons; Levofloxacin; Opportunistic Infections; Plasmids; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Opportunistic Infections; Polymyxin B; Retrospective Studies; Transplantation, Homologous; Young Adult | 2015 |
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cystic Fibrosis; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Opportunistic Infections; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Quinolones | 2005 |